Clinical Trials in New York

Showing 3681-3700 of 22,668 trials

Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

NCT04631744

The purpose of this study is to determine what effects (good and bad) cabozantinib has in treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). The hypothesis for this trial is that cabozantinib has anti-tumor activity in a molecularly-selected group of patients with CRPC or patients with liver metastases.

Prostate Cancer

Weill Medical College of Cornell University4 participantsStarted Mar 2021

New York, New York, United States

COMPLETEDPhase 3< 1 mile

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

NCT03009981

This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.

Prostate Cancer

Alliance Foundation Trials, LLC.504 participantsStarted Mar 2017

Phoenix, Arizona, United States • Chula Vista, California, United States • Duarte, California, United States +66 more locations

Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Find Trials by Condition in New York

A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation

Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse

A Personalized Voice Restoration Device for Patients With Laryngectomy

The Johns Hopkins Heartburn Center Registry

Cardiovascular Analysis of PEM

A Study of Amivantamab and Lazertinib in People With Non-Small Cell Lung Cancer (NSCLC)

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Gamete Treatment to Correct Fertilization Failure

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)

Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease

Study of Aspirin in Patients With Vestibular Schwannoma

Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID